References
- Profyris C, Tziotzios C, Do V, I. Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation. J Am Acad Dermatol. 2012;66:1–10
- Tiwari VK. Burn wound: how it differs from other wounds? Indian J Plast Surg. 2012;45:364–73
- Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17:113–25
- Wang J, Hori K, Ding J, et al. Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol. 2011;226:1265–73
- Taheri A, Mansoori P, Al-Dabagh A, Feldman SR. Are corticosteroids effective for prevention of scar formation after second-degree skin burn? J Dermatol Treat. 2014;25:360–2
- Taheri A, Mansoori P. Topical clobetasol in combination with tretinoin for prevention of scar formation after superficial skin burn. J Expt Dermatol Res. 2014;1:001
- Fassler R, Sasaki T, Timpl R, et al. Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice. Exp Cell Res. 1996;222:111–16
- Kauh YC, Rouda S, Mondragon G, et al. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol. 1997;37:586–9
- Nauck M, Roth M, Tamm M, et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol. 1997;16:398–406
- Hayashi T, Furukawa H, Oyama A, et al. A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision. Dermatol Surg. 2012;38:893–7
- Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol. 1997;37:755–7
- Chowdri NA, Masarat M, Mattoo A, Darzi MA. Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg. 1999;69:655–9
- Sclafani AP, Gordon L, Chadha M, Romo T III. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: a randomized, prospective study and review of the literature. Dermatol Surg. 1996;22:569–74
- Stucker FJ, Shaw GY. An approach to management of keloids. Arch Otolaryngol Head Neck Surg. 1992;118:63–7
- Rosen DJ, Patel MK, Freeman K, Weiss PR. A primary protocol for the management of ear keloids: results of excision combined with intraoperative and postoperative steroid injections. Plast Reconstr Surg. 2007;120:1395–400
- Janssen de Limpens AM. The local treatment of hypertrophic scars and keloids with topical retinoic acid. Br J Dermatol. 1980;103:319–23
- Panabiere-Castaings MH. Retinoic acid in the treatment of keloids. J Dermatol Surg Oncol. 1988;14:1275–6
- Parsad D, Saini R, Juneja A. Combination of clobetasol and tretinoin in vitiligo -letter-. Int J Dermatol. 2000;39:639–40
- Choi YH, Kim KM, Kim HO, et al. Clinical and histological correlation in post-burn hypertrophic scar for pain and itching sensation. Ann Dermatol. 2013;25:428–33
- Blaha J. Physiology and pathology of skin after burns and derangement of gene expression. Acta Chir Plast. 2006;48:127–32
- Broughton G, Janis JE, Attinger CE. Wound healing: an overview. Plast Reconstr Surg. 2006;117:1e–32e
- Shih B, Garside E, McGrouther DA, Bayat A. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen. 2010;18:139–53
- Kondo T, Ishida Y. Molecular pathology of wound healing. Forensic Sci Int. 2010;203:93–8
- Moulin V, Larochelle S, Langlois C, et al. Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol. 2004;198:350–8
- Wolfram D, Tzankov A, Pulzl P, Piza-Katzer H. Hypertrophic scars and keloids – a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009;35:171–81
- Ashley FL. Atrophy following cortisone injection for hypertrophic scar. Calif Med. 1973;119:65–6
- Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560–71
- Uchida G, Yoshimura K, Kitano Y, et al. Tretinoin reverses upregulation of matrix \\metalloproteinase-13 in human keloid-derived fibroblasts. Exp Dermatol. 2003;12:35–42
- McCormack MC, Nowak KC, Koch RJ. The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model. Arch Facial Plast Surg. 2001;3:28–32
- Abergel RP, Meeker CA, Oikarinen H, et al. Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures. Arch Dermatol. 1985;121:632–5
- Daly TJ, Weston WL. Retinoid effects on fibroblast proliferation and collagen synthesis in vitro and on fibrotic disease in vivo. J Am Acad Dermatol. 1986;15:900–2